Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pino G Cusumano

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 20, 2011
The cancer screening controversyPino G Cusumano, Eric Lifrange
Annals of Surgical Oncology|September 12, 2012
Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patientsBichlien Nguyen, Pino G Cusumano, Kenneth Deck, et al.
Plos Medicine|September 2, 2015
Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast CancerPamela Maris, Arnaud Blomme, Ana Perez Palacios, et al.
Breast Care (Basel, Switzerland)|April 21, 2025
The Challenge of Calculating EUSOMA Quality Indicators with Administrative Data: A Pilot Study in BelgiumRoos Leroy, Cindy De Gendt, Jolyce Bourgeois, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2024
Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres - A population-based study in BelgiumRoos Leroy, Geert Silversmit, Jolyce Bourgeois, et al.
Cell Reports|February 6, 2020
Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to CetuximabJustine Bellier, Marie-Julie Nokin, Maurine Caprasse, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 20, 2011
The cancer screening controversyPino G Cusumano, Eric Lifrange
Annals of Surgical Oncology|September 12, 2012
Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patientsBichlien Nguyen, Pino G Cusumano, Kenneth Deck, et al.
Plos Medicine|September 2, 2015
Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast CancerPamela Maris, Arnaud Blomme, Ana Perez Palacios, et al.
Breast Care (Basel, Switzerland)|April 21, 2025
The Challenge of Calculating EUSOMA Quality Indicators with Administrative Data: A Pilot Study in BelgiumRoos Leroy, Cindy De Gendt, Jolyce Bourgeois, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2024
Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres - A population-based study in BelgiumRoos Leroy, Geert Silversmit, Jolyce Bourgeois, et al.
Cell Reports|February 6, 2020
Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to CetuximabJustine Bellier, Marie-Julie Nokin, Maurine Caprasse, et al.
Pageof 1